EA013644B1 - Фенилсодержащие n-ацильные производные аминов и аминокислот, способ их получения, фармацевтическая композиция и их применение - Google Patents

Фенилсодержащие n-ацильные производные аминов и аминокислот, способ их получения, фармацевтическая композиция и их применение Download PDF

Info

Publication number
EA013644B1
EA013644B1 EA200702072A EA200702072A EA013644B1 EA 013644 B1 EA013644 B1 EA 013644B1 EA 200702072 A EA200702072 A EA 200702072A EA 200702072 A EA200702072 A EA 200702072A EA 013644 B1 EA013644 B1 EA 013644B1
Authority
EA
Eurasian Patent Office
Prior art keywords
hydrogen
general formula
hydroxyl group
compound
group
Prior art date
Application number
EA200702072A
Other languages
English (en)
Russian (ru)
Other versions
EA200702072A1 (ru
Inventor
Владимир Евгеньевич НЕБОЛЬСИН
Татьяна Александровна КРОМОВА
Галина Александровна ЖЕЛТУХИНА
Виолетта Леонидовна Ковалева
Original Assignee
Общество С Ограниченной Ответственностью "Фарминтерпрайсез"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество С Ограниченной Ответственностью "Фарминтерпрайсез" filed Critical Общество С Ограниченной Ответственностью "Фарминтерпрайсез"
Publication of EA200702072A1 publication Critical patent/EA200702072A1/ru
Publication of EA013644B1 publication Critical patent/EA013644B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C07C233/13—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EA200702072A 2005-03-25 2006-03-24 Фенилсодержащие n-ацильные производные аминов и аминокислот, способ их получения, фармацевтическая композиция и их применение EA013644B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2005108492/04A RU2309144C2 (ru) 2005-03-25 2005-03-25 Фенилсодержащие n-ацильные производные аминов, способ их получения, фармацевтическая композиция и их применение в качестве противовоспалительных и анальгетических средств
PCT/RU2006/000139 WO2006101422A1 (fr) 2005-03-25 2006-03-24 Derives n-acyles d'amines et d'acides amines amines contenant des phenyles, procede de fabrication, composition pharmaceutique et son utilisation

Publications (2)

Publication Number Publication Date
EA200702072A1 EA200702072A1 (ru) 2008-02-28
EA013644B1 true EA013644B1 (ru) 2010-06-30

Family

ID=37024023

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200702072A EA013644B1 (ru) 2005-03-25 2006-03-24 Фенилсодержащие n-ацильные производные аминов и аминокислот, способ их получения, фармацевтическая композиция и их применение

Country Status (18)

Country Link
US (2) US8309766B2 (enExample)
EP (1) EP1876169B1 (enExample)
JP (1) JP5384096B2 (enExample)
KR (1) KR101383580B1 (enExample)
CN (1) CN101180267B (enExample)
CA (1) CA2602545C (enExample)
CY (1) CY1117449T1 (enExample)
DK (1) DK1876169T3 (enExample)
EA (1) EA013644B1 (enExample)
ES (1) ES2564238T3 (enExample)
HU (1) HUE027009T2 (enExample)
MX (1) MX2007011852A (enExample)
PL (1) PL1876169T3 (enExample)
PT (1) PT1876169E (enExample)
RU (1) RU2309144C2 (enExample)
SI (1) SI1876169T1 (enExample)
UA (1) UA88688C2 (enExample)
WO (1) WO2006101422A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2716258C1 (ru) * 2019-07-30 2020-03-11 Автономная некоммерческая образовательная организация высшего образования Сколковский институт науки и технологий Пептидный антагонист нмда-рецептора

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7642290B2 (en) 2002-10-03 2010-01-05 Novaremed Limited Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
US7674829B2 (en) 2004-03-26 2010-03-09 Novaremed Limited Compounds for the treatment of AIDS and other viral diseases
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
WO2009132978A1 (en) * 2008-04-29 2009-11-05 F. Hoffmann-La Roche Ag 4-dimethylaminobutyric acid derivatives
WO2011030205A1 (en) * 2009-09-09 2011-03-17 Novaremed Ltd. N-substituted benzenepropanamide or benzenepropenamide for use in the treatment of pain and inflammation
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
CN103221383B (zh) * 2010-08-27 2016-04-20 株式会社新药 促进人源性抗菌肽分泌的新化合物、其制备方法以及含有其作为活性成分的组合物
GB201116335D0 (en) * 2011-09-21 2011-11-02 Novaremed Ltd A method of treating or preventing affective disorders
ES2578377B1 (es) * 2014-12-22 2017-05-04 Consejo Superior De Investigaciones Científicas (Csic) Compuestos moduladores del sensor neuronal de calcio dream y sus usos terapéuticos.
RU2690188C2 (ru) * 2017-05-26 2019-05-31 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Новый мультитаргетный препарат для лечения заболеваний у млекопитающих
JP2021509398A (ja) * 2017-08-21 2021-03-25 プレックス ファーマスーティカルズ，インク 二重作用ｆｋｂｐ１２およびｆｋｂｐ５２阻害剤
RU2678563C1 (ru) * 2017-10-27 2019-01-30 Михаил Владимирович Овчинников Водорастворимые производные тирозина, обладающие анальгетическим, противовоспалительным и противоотечным действием
RU2697414C1 (ru) * 2018-05-11 2019-08-14 Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс" Новый антагонист тахикининовых рецепторов и его применение
RU2727703C2 (ru) * 2018-10-29 2020-07-23 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Новый способ получения (S)-2-(2-(4-гидроксифенил)ацетамидо)-3-фенилпропановой кислоты
CN117886714A (zh) * 2024-01-16 2024-04-16 中国药科大学 丙氨酸衍生物、其制备方法及医药用途

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223016A (en) * 1977-06-29 1980-09-16 Beecham Group Limited Peptides
JPS57193437A (en) * 1981-05-21 1982-11-27 Ajinomoto Co Inc Amino acid derivative
WO1997023202A1 (en) * 1995-12-22 1997-07-03 STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of THE OREGON HEALTH SCIENCES UNIVERSITYA ND THE UNIVERSITY OF OREGON, EUGENE OREGON Subtype-selective nmda receptor ligands and the use thereof
USRE37160E1 (en) * 1990-06-12 2001-05-01 Rutgers, The State University Synthesis of tyrosine derived diphenol monomers
RU2233289C2 (ru) * 2002-11-04 2004-07-27 Институт органического синтеза Уральского отделения РАН Способ получения дипептидов

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2711656A1 (de) * 1977-03-17 1978-09-21 Basf Ag Neue pyridin-3-ole
JPS57145891A (en) * 1981-03-05 1982-09-09 Sagami Chem Res Center Optically active diphosphine ligand
ES8607214A1 (es) * 1985-10-16 1986-06-01 Gema Sa Procedimiento enzimatico de resolucion de n-fenilacetil-ami-nocompuestos y purificacion de sus isomeros opticamente ac- tivos
US5403851A (en) * 1994-04-05 1995-04-04 Interneuron Pharmaceuticals, Inc. Substituted tryptamines, phenalkylamines and related compounds
US6319492B1 (en) * 1996-11-27 2001-11-20 Rutgers, The State University Copolymers of tyrosine-based polyarylates and poly(alkylene oxides)
US5912225A (en) * 1997-04-14 1999-06-15 Johns Hopkins Univ. School Of Medicine Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine ester) compounds, compositions, articles and methods for making and using the same
JPH11127894A (ja) * 1997-10-30 1999-05-18 Ono Pharmaceut Co Ltd カルボキシペプチダーゼａ活性測定方法および測定用キット
RU2123041C1 (ru) * 1998-04-02 1998-12-10 Пипия Гулади Эрастович Бальзам "саратовский"
AU761458B2 (en) * 1998-04-13 2003-06-05 Rutgers, The State University The construction of copolymer libraries
WO1999055330A1 (en) * 1998-04-27 1999-11-04 Smithkline Beecham Corporation Ccr-3 receptor antagonists
US6414173B1 (en) * 1998-07-02 2002-07-02 University Of Maryland Hypervalent silane and siloxane derivatives and the use thereof
DE60116200T2 (de) * 2000-03-09 2006-08-17 Tokuyama Corp., Shunan Verfahren zur lagerung quaternärer ammonium-salze
HUP0303085A2 (hu) * 2000-09-27 2003-12-29 The Procter & Gamble Co. Melanokortin receptor ligandumok és ezeket tartalmazó gyógyszerkészítmények
US7642290B2 (en) * 2002-10-03 2010-01-05 Novaremed Limited Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223016A (en) * 1977-06-29 1980-09-16 Beecham Group Limited Peptides
JPS57193437A (en) * 1981-05-21 1982-11-27 Ajinomoto Co Inc Amino acid derivative
USRE37160E1 (en) * 1990-06-12 2001-05-01 Rutgers, The State University Synthesis of tyrosine derived diphenol monomers
WO1997023202A1 (en) * 1995-12-22 1997-07-03 STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of THE OREGON HEALTH SCIENCES UNIVERSITYA ND THE UNIVERSITY OF OREGON, EUGENE OREGON Subtype-selective nmda receptor ligands and the use thereof
RU2233289C2 (ru) * 2002-11-04 2004-07-27 Институт органического синтеза Уральского отделения РАН Способ получения дипептидов

Non-Patent Citations (18)

* Cited by examiner, † Cited by third party
Title
AUZEIL NICOLAS et al. Electrochemical removal of the picolinoyl group under mild acidic conditions, Tetrahedron letters, 1997, v.38(13), p.2283-2286 & NOSHO YASUHARU et al. Studies model of bitter including arginine, proline and phenylalanme residues, Agricultural and biological chemistry, 1985, v.49(6), p.1829-3837 (referat), [on-layn]. Naydeno iz bazy dannykh ACS on STN, on STN, CA 126:330844,103:86669 *
BANERJEE IPSITA A. et al. From peptide nanospheres to nanorods at interfaces, American Chemical Society, Division of Polymer Chemistry, 2005, 46(2), p.746-747 (referat), [on-layn]. Naydeno iz bazy dannykh ACS on STN, CA 144: 274530 *
BASHAROV M.A. i dr. Vliyanie bokovykh radikalov na strukturu peptidov. Poverkhnosti potentsial'noy energii model'nykh dipeptidov alanina i fenilalanina, Molekuryanaya biologiya, 1988, t.22, vyp.5, s.1219-1224 *
GUSCHINA A.E. et al. Structure of pepsin.II. Active site of the enzyme (resolution 2A), Molekulyarnaya Biologiya, 1985, v.19(1), p.225-229 (referat), [on-layn]. Naydeno iz bazy dannykh ACS on STN, CA 103:34106 *
IVANOV G.G. i dr. Vliyanie taurina i dipeptida Tyr-Tyr na defibrilyatsiyu zheludochkov serdtsa, Byulleten' eksperimental'noy biologii i meditsiny, 1992, t.113(5), s.463-464 *
KARNAUCHOV E.N. et al. Synthesis of peptide fragments of the protein-chromophre binding site in bacteriorhodopsin, 1979, v.9(2), p.47-54 (referat), [on-layn]. Naydeno iz bazy dannykh ACS on STN, CA 95:62668 *
KOTLOVA E.K. i dr. Obrazovanie dipeptidov - pobochnaya reaktsiya pri ratsemizatsii fenilalanina, BIOORGANICHESKAYA KHIMIYA, 1999, t.5, No. 9, s.652-657 *
KOZLOV L.V. et al. EFFECT of pH on the mechanism of action of pepsin, 1973 (Russian), Khim. Proteoliticheskikh Fermentov, Mater. Vses. Simp., Meeting Date 1973, 111, Inst. Biokhim.: Vilnus, USSR, (Russian), 1973 (referat), [on-layn]. Naydeno iz bazy dannykh ACS on STN, CA 82:166598 *
KOZLOV L.V. et al. Free energy of peptide bond hydrolysis and enzymic synthesis of N-acetyldipeptide esters., Biokhimiya, 1966, v.31(2), p.315-321 (referat), [on-layn]. Naydeno iz bazy dannykh ACS on STN, CA 65:22005 *
KRUPYANKO V.I. i dr. Nekotorye fiziko-khimicheskie i kineticheskie svoystva metalloproteinazy bakterioliticheskogo preparata lizoamidazy, Biokhimiya, 1990, t.55, vyp.7, s.1279-1286, tabl. 3 *
LISICHKINA I.N. i dr. Gidrirovanie proizvodnykh degidroaminokislot v prisutstvii kompleksov palladiya(II) s metioninom, Izvestiya Akademii nauk, Seriya khimicheskaya, 1988, No. 5, s.1170-1172 *
LO LEE CHIANG et al. Separation of diastereomers of protected dipeptides by normal-phase high-performance liquid chromatography, Journal of chromatography, 1989, v.472(1), r.336-339 (referat), [on-layn]. Naydeno iz bazy dannykh ACS on STN, CA 112:131607 *
LYUBEZNOVA M.R. i dr. Asimmetricheskiy sintez aminokislot putem kataliticheskogo vosstanovleniya azlaktonov atsilaminoakrilovykh kislot, Izvestiya Akademii nauk, Seriya khimicheskaya, 1990, No. 4, s. 811-818, soed. III, s. 817 *
SHVACHKIN Yu.P. et al. Natural peptides and their analogs, Bioorganicheskaya Khimia, 1985 (Russian), v.11(8), r.1026-1036, (referat), [on-layn]. Naydeno iz bazy dannykh ACS on STN, CA 104:225198 *
STEFANE B. 3-Acyl-1,3-diaryltriazenes as neutral and selective acylating agents, TETRAHEDRON LETTERS, 2001, v.42(38), p.6659-6662, soed. 8, 11, 12 *
STEPANOV V.M. et al. Biospecific chromatography of chymosin, 1976, v. 41(2), p.294-303 (referat), [on-layn]. Naydeno iz bazy dannykh ACS on STN, CA 84:160982 *
TANGPASUTHADOL V. et al. Hydrolytic degradation of tyrosine-derived polycarbonates, a class of new biomaterials. Part I. Study of model compounds, BIOMATERIALS, 2000, v.21(23), p.2371-2378, soed. (1), (7) *
TERADA SHIGEYUKI et al. Action of pepsin on synthetic substrates., JOURNAL OF BIOCHEMISTRY, 1971, v.70(1), p.133-142 (referat), [on-layn]. Naydeno iz bazy dannykh ACS on STN, CA 75:94886 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2716258C1 (ru) * 2019-07-30 2020-03-11 Автономная некоммерческая образовательная организация высшего образования Сколковский институт науки и технологий Пептидный антагонист нмда-рецептора

Also Published As

Publication number Publication date
CA2602545C (en) 2014-08-19
DK1876169T3 (en) 2016-03-07
CA2602545A1 (en) 2006-09-28
US8546612B2 (en) 2013-10-01
ES2564238T3 (es) 2016-03-21
WO2006101422A1 (fr) 2006-09-28
CN101180267B (zh) 2015-06-17
EA200702072A1 (ru) 2008-02-28
KR101383580B1 (ko) 2014-04-09
CY1117449T1 (el) 2017-04-26
RU2309144C2 (ru) 2007-10-27
SI1876169T1 (sl) 2016-05-31
JP5384096B2 (ja) 2014-01-08
US20090111874A1 (en) 2009-04-30
UA88688C2 (ru) 2009-11-10
CN101180267A (zh) 2008-05-14
EP1876169A1 (en) 2008-01-09
EP1876169B1 (en) 2015-12-30
PL1876169T3 (pl) 2016-06-30
HUE027009T2 (en) 2016-10-28
US20130109880A1 (en) 2013-05-02
HK1118798A1 (en) 2009-02-20
KR20080008345A (ko) 2008-01-23
JP2008534495A (ja) 2008-08-28
MX2007011852A (es) 2008-02-21
US8309766B2 (en) 2012-11-13
PT1876169E (pt) 2016-03-21
EP1876169A4 (en) 2009-11-04
RU2005108492A (ru) 2006-10-10

Similar Documents

Publication Publication Date Title
US8546612B2 (en) Phenyl-N-acyl derivatives of amines and amino acids, a process for the preparation thereof, a pharmaceutical composition and use thereof
EP4172145B1 (en) Tryptamine prodrugs as serotonin receptor activators for the treatment of e.g. depression
TWI286474B (en) Novel esters that are derived from indolealkanols and novel amides that are derived from indolealkylamines and the esters and the amides are selective COX-2 inhibitors
JPH05501864A (ja) 化合物
CA3240633A1 (en) Tryptamine prodrugs
JP2009528290A (ja) 筋肉病の処置のためのｐａｉ−１阻害剤
FR2896799A1 (fr) Derives de sulfonamides, leur preparation et leur application en therapeutique
EP0475214B1 (en) Caffeic acid derivatives and pharmaceutical compositions containing the same
CA2610805A1 (fr) Derives de 4,5-diarylpyrrole, leur preparation et leur application en therapeutique
FR2584070A1 (fr) Nouveaux derives de l'hydroxy alkoxy 4-phenyl propyl indole, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant.
AU605865B2 (en) Beta-(fluoromethylene)-5-hydroxytryptophan and derivatives as prodrugs for mao inhibition
HU212936B (en) Process for producing (2r)-methyl-4,4,4-trifluorobutylamine
WO2015046405A1 (ja) 鎮痛剤
FR2583047A1 (fr) Procede de preparation de derives du 4-phenylpropyl indole, et intermediaires
HK40114112A (zh) 色胺前药
WO2003099819A2 (fr) Derives d'oxophenyl-cyclohexyl-propanolamine, leur preparation et leur application en therapeutique
HK1118798B (en) Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof
IE43448B1 (en) Substitued pheylacetic acids

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM KG MD TJ TM